Variables | Risk ratio | Univariate 95%CI | P value | Risk ratio | Multivariate 95%CI | P value |
---|---|---|---|---|---|---|
Age (years) | ||||||
≤ 53/ > 53 | 1.768 | (0.981–3.187) | 0.058 | |||
FIGO stage | ||||||
III/IV | 1.518 | (0.838–2.751) | 0.168 | |||
PS | ||||||
0/1 | 0.832 | (0.450–1.537) | 0.557 | |||
NAC cycles | ||||||
1,2/3,4 | 1.522 | (0.799–2.900) | 0.202 | |||
CA-125 value (U/mL) | ||||||
≤ 670/ > 670 | 0.748 | (0.406–1.380) | 0.354 | |||
≤ 100/ > 100 | 0.770 | (0.182–3.258) | 0.722 | |||
Residual disease | ||||||
R0/R1 | 0.207 | (0.073–0.588) | 0.003 | 0.180 | (0.064–0.509) | 0.001 |
BMI | ||||||
≤ 23/ > 23 | 1.518 | (0.838–2.751) | 0.168 | |||
CA-125 drop rate | ||||||
≥ 90%/ < 90% | 0.743 | (0.408–1.354) | 0.332 | |||
≥ 95%/ < 95% | 0.565 | (0.261–1.222) | 0.147 | |||
≤ 100/ > 100U/mL | 0.728 | (0.405–1.309) | 0.289 | |||
NAC regimens | ||||||
Nab-TC/TC | 0.492 | (0.271–0.894) | 0.02 | 0.411 | (0.224–0.753) | 0.004 |